Abstract
Psychotropic medications are an important treatment approach to mental health disorders; such disorders are common in the elderly population. Elderly patients are more likely to experience adverse effects from these agents than their younger counterparts due to age-related changes in pharmacodynamic and pharmacokinetic parameters. Because of these factors, inappropriate use of psychotropic medications in elderly patients has become a focus of concern.
In general an agent is considered inappropriate if the risk associated with its use exceeds its benefit. Implicit and explicit criteria for inappropriate use of medications in the elderly have been created and include psychotropic agents. These criteria vary in their make-up but the explicit criteria tend to agree that amitriptyline, doxepin, and benzodiazepines that have long half-lives are not appropriate.
Although explicit inappropriate medication criteria have been in existence since 1991, elderly patients continue to receive inappropriate psychotropic medications. A wide array of factors may be responsible for this practice. Provider-related causes include deficits in knowledge, confusion due to the lack of a consensus on the inappropriate psychotropic criteria, difficulties in addressing an inappropriate medication started by a previous provider, multiple prescribers and pharmacies involved in the care of a patient, negative perceptions regarding aging, and cost issues. Patients may contribute to the problem by demanding an inappropriate medication. Finally, the healthcare setting may inadvertently contribute to inappropriate prescribing by such policies as restrictive formularies or lack of reimbursement for pharmacists’ clinical services.
Successful approaches to optimising prescribing have been either educational or administrative. Educational approaches (e.g. one-on-one sessions, academic detailing) seek to influence decision making, while administrative approaches attempt to enforce policies to curtail the undesired practice. The US Omnibus Budget Reconciliation Act of 1987, which improved psychotropic medication use in long-term care, is an excellent example of administrative intervention.
More research specifically focused on the causes of inappropriate psychotropic medication use and methods to avoid this practice is needed before targeted recommendations can be made.
Similar content being viewed by others
References
Grossberg GT, Grossberg JA. Epidemiology of psychotherapeutic drug use in older adults. Clin Geriatr Med 1998 Feb; 14(1): 1–5
Jenike MA. Psychiatric illnesses in the elderly: a review. J Geriatr Psychiatry Neurol 1996 Apr; 9: 57–82
Naranjo CA, Herrmann N, Mittmann N, et al. Recent advances in geriatric psychopharmacology. Drugs Aging 1995; 7(3): 184–202
Olsen RB, Gydesen SU, Kristensen M, et al. Psychotropic medication in the elderly: a survey of prescribing and clinical outcome. Dan Med Bull 1990 Oct; 37(5): 455–9
Gurvich T, Cunningham JA. Appropriate use of psychotropic drugs in nursing homes. Am Fam Physician 2000 Mar; 61(5): 1437–46
Lebowitz BD, Pearson JL, Cohen GD. Older Americans and their illnesses. In: Salzman C, editor. Clinical geriatric psychopharmacology. 3rd ed. Baltimore (MD): Williams & Wilkins, 1998: 3–20
Zubenko GS, Sunderland T. Geriatric psychopharmacology: why does age matter? Harv Rev Psychiatry 2000 Mar–Apr; 7(6): 311–33
Ried LD, Christensen DB, Stergachis A. Medical and psychosocial factors predictive of psychotropic drug use in elderly patients. Am J Public Health 1990 Nov; 80(11): 1349–53
Dealberto MJ, Seeman T, McAvay GJ, et al. Factors related to current and subsequent psychotropic drug use in an elderly cohort. J Clin Epidemiol 1997; 50(3): 357–64
Fichter MM, Witzke W, Leibl K, et al. Psychotropic drug use in a representative community sample: the Upper Bavarian study. Acta Psychiatr Scand 1989; 80: 68–77
Michocki RJ, Lamy PP, Hooper FJ, et al. Drug prescribing for the elderly. Arch Fam Med 1993 Apr; 2: 441–4
Avorn J. Drug prescribing, drug taking, adverse reactions, and compliance in elderly patients. In: Salzman C, editor. Clinical geriatric psychopharmacology. 3rd ed. Baltimore (MD): Williams & Wilkins, 1998: 21–47
Lasser RA, Sunderland T. Newer psychotropic medication use in nursing home residents. J Am Geriatr Soc 1998 Feb; 46(2): 202–7
Parker BM, Cusack BJ, Vestal RE. Pharmacokinetic optimisation of drug therapy in elderly patients. Drugs Aging 1995; 7(1): 10–8
Aparasu RR, Mort JR, Sitzman S. Psychotropic prescribing for the elderly in office-based practice. Clin Ther 1998; 20(3): 603–16
Mort JR, Aparasu RR. Prescribing potentially inappropriate psychotropic medications to the ambulatory elderly. Arch Intern Med 2000 Oct; 160: 2825–31
Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med 1991 Sept; 151: 1825–32
Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. Arch Intern Med 1997 July; 157: 1531–6
Fouts M, Hanlon J, Pieper C, et al. Identification of elderly nursing facility residents at high risk for drug-related problems. Consultant Pharmacist 1997 Oct; 12(10): 1103–11
McLeod PJ, Huang AR, Tamblyn RM, et al. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. Can Med Assoc J 1997 Feb; 156(3): 385–91
Hanlon JT, Schmader KE, Samsa GP, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992; 45(10): 1045–51
Aparasu RR, Fliginger SE. Inappropriate medication prescribing for the elderly by office-based physicians. Ann Pharmacother 1997 Jul–Aug; 31: 823–9
Aparasu RR, Sitzman SJ. Inappropriate prescribing for elderly outpatients. Am J Health Syst Pharm 1999 Mar 1; 56(5): 433–9
Beers MH, Ouslander JG, Fingold SF, et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med 1992 Oct; 117(8): 684–9
Golden AG, Preston RA, Barnett SD, et al. Inappropriate medication prescribing in homebound older adults. J Am Geriatr Soc 1999 Aug; 47(8): 948–53
Hanlon JT, Fillenbaum GG, Schmader KE, et al. Inappropriate drug use among community-dwelling elderly. Pharmacotherapy 2000; 20(5): 575–82
Piecoro LT, Browning SR, Prince TS, et al. A database analysis of potentially inappropriate drug use in an elderly Medicaid population. Pharmacotherapy 2000; 20(2): 221–8
Spore DL, Mor V, Larrat P, et al. Inappropriate drug prescriptions for elderly residents of board and care facilities. Am J Public Health 1997 Mar; 87(3): 404–9
Stuck AE, Beers MH, Steiner A, et al. Inappropriate medication use in community-residing older persons. Arch Intern Med 1994 Oct; 154: 2195–200
The United States General Accounting Office. Prescription drugs and the elderly: many still receive potentially harmful drugs despite recent improvements. Washington, DC: General Accounting Office, July 1995: GAO/HEHS-95–152
Willcox SM, Himmelstein DU, Woolhandler S. Inappropriate drug prescribing for the community-dwelling elderly. JAMA 1994 July; 272(4): 292–6
Ancoli-Israel S. Insomnia in the elderly: a review for the primary care practitioner. Sleep 2000; 23Suppl. 1: S23–30
Asplund R. Sleep disorders in the elderly. Drugs Aging 1999 Feb; 14(2): 91–103
Burke WJ, Folks DG, McNeilly DP. Effective use of anxiolytics in older adults. Clin Geriatr Med 1998 Feb; 14(1): 47–65
Folks DG, Burke WJ. Sedative hypnotics and sleep. Clin Geriatr Med 1998 Feb; 14(1): 67–86
Maixner SM, Mellow AM, Tandon R. The efficacy, safety, and tolerability of antipsychotics in the elderly. J Clin Psychiatry 1999; 60 Suppl. 8: 29–41
Maletta G, Mattox KM, Dysken M. Update 2000. Guidelines for prescribing psychoactive drugs. Geriatrics 2000 Mar; 55(3): 65–79
Newhouse PA. Use of serotonin selective reuptake inhibitors in geriatric depression. J Clin Psychiatry 1996; 57 Suppl. 5: 12–22
Schneider LS. New therapeutic approaches to cognitive impairment. J Clin Psychiatry 1998; 59 Suppl. 11: 8–13
Sloane PD. Advances in the treatment of Alzheimer’s disease. Am Fam Physician 1998 Nov; 58(7): 1577–86
Sweet RA, Pollock BG. New atypical antipsychotics: experience and utility in the elderly. Drugs Aging 1998 Feb; 12(2): 115–27
Zisook S, Downs NS. Diagnosis and treatment of depression in late life. J Clin Psychiatry 1998; 59 Suppl. 4: 80–91
HCFA Interpretive Guidelines. Guidance to surveyors — long term care facilities. 483.25 (1)(1), tag number F329 Unnecessary drugs, rev 274, 1007-99; 483.25(l)(2)(i)-(ii), tag numbers F330-1 Antipsychotic drugs, rev 274, 1007-99; 483.60(c)(2), tag number F429 Drug regimen review, rev 1007-99
Batty GM, Oborne CA, Swift CG, et al. Development of an indicator to identify inappropriate use of benzodiazepines in elderly medical in-patients. Int J Geriatr Psychiatry 2000; 15: 892–6
Schmader K, Hanlon JT, Weinberger M, et al. Appropriateness of medication prescribing in ambulatory elderly patients. J Am Geriatr Soc 1994 Dec; 42(12): 1241–7
Fitzgerald LS, Hanlon JT, Shelton PS, et al. Reliability of a modified medication appropriateness index in ambulatory older persons. Ann Pharmacother 1997 May; 31: 543–8
Tamblyn R. Medication use in seniors: challenges and solutions. Therapie 1996; 51: 269–82
Avorn J. Medication use and the elderly: current status and opportunities. Health Aff 1995; 14(1): 276–86
Beers MH, Baran RW, Frenia K. Drugs and the elderly, part 2: strategies for improving prescribing in a managed care environment. Am J Manag Care 2001 Jan; 7(1): 69–72
Posey LM. The geriatric pharmacy Swiss cheese education in America approach. Consultant Pharmacist 1992 Jan; 7(1): 8–15
Avorn J, Gurwitz JH. Drug use in the nursing home. Ann Intern Med 1995 Aug; 123(3): 195–204
Damestoy N, Collin J, Lalande R. Prescribing psychotropic medication for elderly patients: some physicians’ perspectives. Can Med Assoc J 1999 Jul; 161(2): 143–5
Britten N, Brant S, Cairns A, et al. Continued prescribing of inappropriate drugs in general practice. J Clin Pharm Ther 1995; 20: 199–205
Beers MH, Fingold SF, Ouslander JG, et al. Characteristics and quality of prescribing by doctors practicing in nursing homes. J Am Geriatr Soc 1993 Aug; 41(8): 802–7
Drug topics red book 2000. Montvale (NJ): Medical Economics, 2000
American Society of Health-System Pharmacists. American hospital formulary service drug information, 2001. Bethesda (MD): American Society of Health-System Pharmacists, Inc., 2001
Avorn J, Soumerai SB. Improving drug-therapy decisions through educational outreach: a randomized controlled trial of academically based ‘detailing’. N Engl J Med 1983 Jun; 308(24): 1457–63
Beers MH, Fingold SF, Ouslander JG, et al. Decreasing inappropriate prescribing in nursing homes. J Am Geriatr Soc 1993 Oct; 41(10): sa6
Bootman JL, Harrison DL, Cox E. The health care cost of drug-related morbidity and mortality in nursing facilities. Arch Intern Med 1997 Oct; 157(18): 2089–96
De Burgh S, Mant A, Mattick RP, et al. A controlled trial of educational visiting to improve benzodiazepine prescribing in general practice. Aust J Public Health 1995 Apr; 19(2): 142–8
De Santis G, Harvey KJ, Howard D, et al. Improving the quality of antibiotic prescription patterns in general practice: the role of educational intervention. Med J Aust 1994 Apr; 160(8): 502–5
Ekedahl A, Andersson SI, Hovelius B, et al. Drug prescription attitudes and behaviour of general practitioners. Effects of a problem-oriented educational programme. Eur J Clin Pharmacol 1995; 47(5): 381–7
Figueiras A, Sastre I, Tato F, et al. One-to-one versus group sessions to improve prescription in primary care. Med Care 2001 Feb; 39(2): 158–67
Gurwitz JH, Soumerai SB, Avorn J. Improving medication prescribing and utilization in the nursing home. J Am Geriatr Soc 1990 May; 38(5): 542–52
Hanlon JT, Weinberger M, Samsa GP, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 1996 Apr; 100: 428–37
Hughes CM, Lapane KL, Mor V, et al. The impact of legislation on psychotropic drug use in nursing homes: a cross-national perspective. J Am Geriatr Soc 2000 Aug; 48(8): 931–7
Lantz MS, Giambanco V, Buchalter EN. A ten-year review of the effect of OBRA-87 on psychotropic prescribing practices in an academic nursing home. Psychiatr Serv 1996 Sep; 47(9): 951–5
Lipton HL, Bero LA, Bird JA, et al. The impact of clinical pharmacists’ consultations on physicians’ geriatric drug prescribing: a randomized controlled trial. Med Care 1992 Jul; 30(7): 646–58
Monane M, Matthias DM, Nagle BA, et al. Improving prescribing patterns for the elderly through an online drug utilization review intervention. JAMA 1998 Oct; 280(14): 1249–52
Stross JK, Bole GG. Evaluation of a continuing education program in rheumatoid arthritis. Arthritis Rheum 1980 Jul; 23(7): 846–9
Raisch DW A model of methods for influencing prescribing: part 1. A review of prescribing models, persuasion theories, and administrative and educational methods. DICP 1990 Apr; 24: 417–21
Pippalla RS, Riley DA, Chinburapa V. Influencing the prescribing behaviour of physicians: a metaevaluation. J Clin Pharm Ther 1995; 20: 189-98
Acknowledgements
The authors have no potential conflicts of interest that are directly relevant to the contents of this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mort, J.R., Aparasu, R.R. Prescribing of Psychotropics in the Elderly. Mol Diag Ther 16, 99–109 (2002). https://doi.org/10.2165/00023210-200216020-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00023210-200216020-00003